Bausch Health
BHC
#4240
Rank
NZ$4.38 B
Marketcap
NZ$11.82
Share price
-1.59%
Change (1 day)
-11.37%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): NZ$1.65

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ$1.68. In 2024 the company made an earnings per share (EPS) of NZ-$0.21 an increase over its 2023 EPS that were of NZ-$2.81.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.65-891.24%
2024NZ-$0.21-92.59%
2023NZ-$2.81160.89%
2022NZ-$1.08-76.64%
2021NZ-$4.6168.45%
2020NZ-$2.74-68.91%
2019NZ-$8.80-57.11%
2018NZ-$20.51-272.22%
2017NZ$11.91-199.29%
2016NZ-$12.00798.7%
2015NZ-$1.33-128.31%
2014NZ$4.71-204.62%
2013NZ-$4.51602.7%
2012NZ-$0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.65-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ-$0.42-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA